PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Pylote & Pharmaster Sign A Mutual Referencing Agreement To Offer Innovative & Secure Unpreserved Opthalmic Solutions

Pylote, the new player in the green mineral chemical sector, and Pharmaster, a specialist large-scale production and industrialisation of sterile non-injectable liquids and aseptic filling, announced the signature of a mutual referencing agreement to offer to their respective clients innovative & secure unpreserved ophthalmic solutions.
Part of the Synerlab Group, Pharmaster brings its know how in large-scale production and industrialization of sterile non-injectable liquids, with or without preservatives, but also its expertise in the aseptic filling of solutions for ophthalmic application.
Pylote brings its breakthrough innovation, PYCLEARTM PROTECTION that protects patients from all risks of external microbial contamination and preservative side effects, without any change in the industrial process or treatment method. Pylote will provide Pharmaster with “Pylote Added” ready to use 3-parts ophthalmic packaging solutions benefiting from the effects of its 2016 industrial agreement with the leading Greek primary plastic packaging producer Argo.
The “Pylote Added” packaging components to be filled on Pharmaster’s aseptic filling lines will bring real competitive advantages in term of safety and antimicrobial protection in full compliance with worldwide regulations (Eur. Ph., USP, JP. Ph. …) by removing the use of preservatives from ophthalmic products, while eliminating all risk of contamination throughout the total duration of use, thus ensuring patient safety.
“This mutual referencing agreement with Pharmaster is the logical continuum of our 2016 industrial partnership in Europe with Argo to offer the ideal “eco-friendly” industrial and cost effective answer to the health authorities concerned by the adverse effects of preservatives in ophthalmic preparations“ said Loïc Marchin, CEO of Pylote.
“The innovative approach of Pylote has earned Pharmaster’s interest and support to offer improved service and alternative technologies to customers” said Claire Klopfenstein, CEO of Pharmaster.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026